Summary
The title compounds were prepared by an enzymatic transdeoxyribosylation from 2′ dGuo or 2′ dThd to the respective heterocyclic bases, 5-ethyluracil and (E)-5-(2-bromovinyl)uracil, using the whole bacterial cells ofEscherichia coli as a biocatalyst.
Similar content being viewed by others
References
Barwolff, D. and Langen, P. (1979) Nucl. Acids Res. Spec. Publ. 1, 29–31.
Barr, P.J., Jones, A.S., Verhelst, G. and Walker R.T. (1981) J. Chem. Soc. Perkin 1 1665–1670.
De Clercq, E. (1988) Recent Advances in the Search for Selective Antiviral Agents. In: Adv. Drug Res. Vol. 17, pp. 1–59; Academic Press.
Eroshevskaya, L.A., Barai, V.N., Zinchenko, A.I., Kvasyuk, E.I. and Mikhailopulo, I.A. (1986) Antibiot. Med. Bioteknol. (Moscow), 31, 174–178.
Holy, A. and Votruba, I. (1987) Nucl. Acids Res. Symp. Ser. 18, 69–72.
Jones, A.S., Verhelst, G. and Walker, R.T. (1979) Tetrahedron Lett. 45, 4415–4418.
Niedballa, U. and Vorbruggen, H. (1974) J. Org. Chem. 39, 3654–3660.
Shapira, J. (1962) J. Org. Chem. 27 1918–1919.
Swierkowski, M and Shugar, D. (1969) J. Med. Chem. 12, 533–534.
Szabolcs, A., Sagi, J. and Otvos, L. (1975) J. Carbohyd. Nucleosides Nucleotides 2, 197–211.
Szabolcs, A., Otvos, L., Sagi, J., Szemzoe, A., Peredy, M., Horvath, I., Koczka, I., Rethati, C. and Ivan, P. (1983) UK Pat., G.B. 2 125399 A; C.A 1983, vol. 99, P 71133 a.
Vorbruggen, H., Krolikiewicz, K. and Bennua, B. (1981) Chem. Ber. 114, 1234–1255.
Vorbruggen, H. and Bennua, B. (1981) Chem. Ber. 114, 1279–1286.
Zinchenko, A.I., Eroshevskaya, L.A., Barai, V.N. and Mikhailopulo, I.A. (1987) Nucl. Acids Res. Symp. Ser. 18, 137–140.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kalinichenko, E.N., Barai, V.N., Bokut, S.B. et al. Microbiological synthesis of 5-ethyl- and (E)-5-(2-bromovinyl)-2′-deoxyuridine. Biotechnol Lett 11, 621–626 (1989). https://doi.org/10.1007/BF01025269
Issue Date:
DOI: https://doi.org/10.1007/BF01025269